Filing Summary
Entity identification: The filing is AlphaVest Acquisition Corp.’s Form 10-K for the year ended December 31, 2023. It does not identify AMC Robotics Corp; investors should confirm that this is the intended filing.
Business context and reporting period
AlphaVest is a Cayman Islands blank-check company formed to pursue a business combination, with an intended initial focus on Asia. It had no operating business or operating revenue through December 31, 2023. Its securities trade on Nasdaq under ATMVU, ATMV and ATMVR.
In August 2023, AlphaVest agreed to combine with Wanshun Technology Industrial Group Limited. The agreement was terminated effective March 18, 2024, after the reporting date; AlphaVest stated Wanshun was to pay a termination fee to the sponsor as soon as reasonably practicable. The filing does not provide a clear amount for that fee or confirm its receipt.
Financial performance, cash flow and liquidity
| Metric | Year ended December 31, 2023 | Prior comparable period |
|---|---|---|
| Operating revenue | None | None |
| Net income (loss) | $2,904,174 | $(42,578), from inception on January 14, 2022 through December 31, 2022 |
| Trust and bank interest income | $3,580,492 | $38,228 |
| Formation and operating costs | $676,318 | $80,806 |
| Net cash used in operating activities | $(630,475) | $0 |
| Cash at year-end | $28,560 | $659,035 |
| Trust investments at year-end | $50,880,604 | $70,418,228 |
Net income primarily reflects interest earned on trust assets, not operating profitability. The trust held U.S. Treasury securities. AlphaVest reported a working-capital deficit of $324,822 at year-end. It had $165,000 outstanding under an unsecured, interest-free sponsor extension note and reported $9,837 due to a related party; it reported no long-term debt or lease obligations.
In December 2023, shareholders redeemed 2,174,171 shares for approximately $23.28 million, or about $10.71 per share. Approximately $50.61 million remained in trust after the redemption; year-end trust investments were reported at $50.88 million. AlphaVest reported 7,006,329 ordinary shares outstanding following the redemption.
No operating margin is meaningful because the company had no operating revenue. The filing reports no dividends and no off-balance-sheet financing arrangements.
Material changes and subsequent events
- Net income increased from a $42,578 loss in the 2022 inception period, largely because trust interest income rose to $3.58 million in 2023.
- At a December 2023 meeting, shareholders approved extensions allowing the business-combination deadline to be extended, in stages, to December 22, 2024. The first extension was funded with $165,000. A further $55,000 deposit in March 2024 extended the deadline to April 22, 2024. The filing does not establish the deadline or company status after April 22.
- On April 15, 2024, the sponsor note was amended to allow principal of up to $715,000 and to mature by September 12, 2024 or promptly after a business combination, whichever occurs first.
- After Nasdaq notified the company in March 2024 of board and audit committee independence deficiencies, AlphaVest appointed an independent director and stated that it had regained compliance.
Outlook, risks and unusual items
Management expects continuing public-company, due-diligence and transaction costs and says additional capital may be needed. Sponsor or affiliate loans are possible but not committed. The auditor’s report and management disclosure state that substantial doubt exists about AlphaVest’s ability to continue as a going concern: it has minimal operating cash, a working-capital deficit, no operating revenue and must liquidate if it does not complete a business combination within the permitted period. The financial statements include no adjustments for the outcome of this uncertainty.
Failure to complete a transaction could result in redemption of public shares and liquidation; rights would expire worthless. Trust funds may also be exposed to creditor claims, potentially reducing amounts returned to shareholders. Other significant risks include limited time and funds to find a target, redemption-related financing constraints, sponsor and management conflicts, potential dilution or debt, Nasdaq listing requirements, and regulatory, currency, data-security and enforcement risks if a target operates in China or elsewhere outside the United States.
Management reported effective disclosure controls and internal control over financial reporting as of December 31, 2023. The auditor issued an unqualified opinion on the financial statements while separately emphasizing the going-concern uncertainty.
Important facts for investors to verify
- Confirm the intended issuer: the supplied filing is for AlphaVest Acquisition Corp, not AMC Robotics Corp.
- Check the company’s current business-combination deadline, trust balance, cash position and liquidation or extension status after April 22, 2024.
- Verify whether Wanshun paid the termination fee to the sponsor and review the termination terms and any related-party implications.
- Reconcile the balance-sheet liability figures: the listed current liabilities total $387,955, while the reported total liabilities are $379,955; the reported working-capital deficit of $324,822 aligns with the listed current-liability total.
- Review the sponsor’s extension-note funding and repayment terms, including the amended maximum principal of $715,000, and assess the company’s ability to fund operations through a transaction or liquidation.